Cannabis Stock News Daily Roundup May 15

Cannabis Stock News Daily Roundup May 15

GrowGeneration (OTCQX: GRWGhas purchased the assets of GreenLife Garden Supply, including two locations in Maine and one in New Hampshire. The acquisition brings the company’s total retail and warehouse locations to five that services the growing number of commercial cultivators in the New England market.

Target Group (OTCQB: CBDY) subsidiary Canary Rx has submitted a site evidence package to Health Canada as part of its cultivation, processing and sales license application under the Cannabis Act.

Grown Rogue International (CSE: GRIN) (OTC: GRUSF) said that its request for a ticker symbol change on the Over the Counter Bulletin Board from “NVSIF” to “GRUSF” has been accepted by the Financial Industry Regulatory Authority (FINRA). The company’s symbol on the Canadian Securities Exchange remains unchanged as “GRIN”.

Medical Marijuana (OTC: MJNAannounced that its investment company AXIM Biotechnologies (OTC: AXIM) has filed a provisional patent application with the United States Patent and Trademark Office. The application is for a patent on a chewing gum composition comprising cannabinoids and parthenolide (feverfew extract) for treatment of symptoms of migraines.

New West Genetics announced that its hemp grain variety NWG-ELITE has been submitted for approval under the newly authorized USDA Plant Variety Protection program. NWG-ELITE is currently the only adapted and AOSCA-certified hemp seed variety produced in the U.S.

Sugarmade (OTCQB: SGMDannounced a new corporate initiative to develop cultivation monitoring systems for hemp and other agricultural commodities. According to the company, the artificial intelligence-driven devices will be placed at various locations within hemp fields to gather vital information about soil moisture, temperature, humidity, etc. and will be data linked back to central control systems.

KBL Merger Corp. IV (NASDAQ: KBLMhas entered into a non-binding term sheet to acquire CannBioRx Life Sciences and its three key programs, which, if completed, will constitute KBL’s qualifying business combination transaction. The transactions are subject to due diligence by the parties, the amalgamation and internal reorganization of CannBioRx and the companies comprising the three programs, the negotiation and execution of definitive agreements and approval by the respective boards of KBL and CannBioRx, as well as the companies’ shareholders.

Indus Holdings (CSE: INDShas agreed to acquire the assets of W The Brand, a manufacturer and distributor of cannabis concentrates, cartridges and disposable pens, in a cash and stock transaction. Under the agreement, Indus will acquire the assets of W Vapes for $10 million in common equity shares (CDN$15.65 per share) and $10 million in cash.

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US: TGODF) has obtained approval from Health Canada under the Cannabis Regulations to expand operations into its new state-of-the-art building located in Hamilton, Ontario. The 20,000-square-feet indoor facility will be used for cannabis cultivation and planting will start in the coming weeks.

Aphria (TSX: APHA) (NYSE: APHAannounced several new executive appointments. The company named James Meiers as chief operating officer, Aphria Leamington as chief information officer, Tim Purdie as chief information security officer, and Maureen Berry as vice president of corporate human resources.

GB Sciences (OTCQB: GBLX) said that it is nearing completion of $700,000 in power and water upgrades at its cultivation facility in Las Vegas, Nev., which will more than triple the company’s flower production capabilities. The upgrades will allow GB Sciences to expand its Las Vegas cultivation facility, currently at 180 active grow lights, to approximately 600 lights total.

Green Peak Innovations, Michigan’s holder of vertical medical marijuana licenses, has entered into an agreement to acquire a company which holds a vertical cannabis license in the state of Florida. The transaction is subject to certain preconditions and regulatory approval. Details are confidential, according to the company.